Antiretroviral Therapy

Evaluation and Management of Virologic Failure

Lesson 5. Evaluation and Management of Virologic Failure

About this Lesson

Learning Objective Performance Indicators

Describe the management of intermittent and persistently detectable HIV RNA levels in persons receiving antiretroviral therapy
Discuss the indications for and types of resistance testing for patients with virologic failure
Utilize an HIV resistance database tool to assist in the optimal selection of regimens in persons with HIV drug resistance
Summarize concepts of resistance with different antiretroviral drug classes
Explain key considerations when selecting a salvage antiretroviral regimen in persons with virologic failure

Activities in this Lesson

Quick ReferenceEvaluation and Management of Virologic Failure Core Concepts

The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

The National HIV Curriculum is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,172,990 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov. This project is led by the University of Washington Infectious Diseases Education and Assessment (IDEA) Program.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.